|
Phase 2 Study assessing AMG 162 in the treatment of women with low bone density Clinical Trials Information presented on Clinical Trials Search isn't designed to be a substitute for certified healthcare advice, travels to or professional assistance using a genuine medical doctor. We are not physicians. Always confer with your dr. about Phase 2 Study assessing AMG 162 in the treatment of women with low bone density conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Phase 2 Study assessing AMG 162 in the treatment of women with low bone density Clinical research trials and Phase 2 Study assessing AMG 162 in the treatment of women with low bone density medical trials happen in hundreds of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually measure the effectualness of new drugs. The intention of the studies / undertakings is to solve certain human healthcare questions. Clinical trials are a popular manner for mDs, government agencies, and private sector companies to locate treatments for all forms of circumstances, such as Phase 2 Study assessing AMG 162 in the treatment of women with low bone density. Phase 2 Study assessing AMG 162 in the treatment of women with low bone density Clinical Trials and other clinical trials allow for volunteers to undergo medical treatment choices before they are available to the general public. Some times the human subjects get treatment for free of charge, and sometimes they are paid for their time. Occasionally there is a cost for a Phase 2 Study assessing AMG 162 in the treatment of women with low bone density clinical trial. Participants frequently get the best healthcare available for their Phase 2 Study assessing AMG 162 in the treatment of women with low bone density condition. Risks are a reality, nonetheless, and can include extra or frequent physician trips, medical risks (possibly life-jeopardising), and/or the treatment being ineffective. Trials are federally governed with exacting guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "P" Clinical Trials Conditions > Phase 2 Study assessing AMG 162 in the treatment of women with low bone density  Phase 2 Study assessing AMG 162 in the treatment of women with low bone density
Phase 2 Study assessing AMG 162 in the treatment of women with low bone density
For Condition: Osteoporosis,Osteopenia
Status: No longer recruiting
Sponsor(s): Amgen ,
Synopsis: Clinical research study of a novel protein, AMG 162, which has been shown in animal studies to regulate bone metabolism by inhibiting the cells that break down bone. This study will evaluate the effect of AMG 162 on bone mineral density in post menopausal women who have low bone mineral density.
Details:
Eligibility:
Study Type: Interventional, Treatment
Minimum Age/Maximum Age: 18 Years/85 Years
Genders: Female
Protocol Entry Criteria: Low bone mineral density, ambulatory, general good health, not currently receiving medication that affects bone metabolism
Total Enrollment:
Location and Contact Information:
Research Site
Palm Springs, Florida,
United States
Research Site
San Diego, California,
United States
Research Site
Ocala, Florida,
United States
Research Site
Beverly Hills, California,
United States
Research Site
Phoenix, Arizona,
United States
Research Site
Orland Park, Illinois,
United States
Research Site
Colorado Springs, Colorado,
United States
Research Site
Daytona, Florida,
United States
Research Site
Lake Worth, Florida,
United States
Research Site
Laguna Woods, California,
United States
Research Site
San Antonio, Texas,
United States
Research Site
Los Angeles, California,
United States
Research Site
Palo Alto, California,
United States
Research Site
Dallas, Texas,
United States
Research Site
Indianapolis, Indiana,
United States
Research Site
Rancho Cucamonga, California,
United States
Research Site
Duncansville, Pennsylvania,
United States
Research Site
Venice, Florida,
United States
Research Site
Lakewood, Colorado,
United States
Research Site
Cincinnati, Ohio,
United States
Research Site
Bethesda, Maryland,
United States
Research Site
Kalamazoo, Michigan,
United States
Research Site
Lakewood, Washington,
United States
Research Site
Elmsford, New York,
United States
Research Site
Lenexa, Kansas,
United States
Research Site
Walnut Creek, California,
United States
Research Site
Leesburg, Florida,
United States
Research Site
Wyomissing, Pennsylvania,
United States
Research Site
Seattle, Washington,
United States
Research Site
San Francisco, California,
United States
Additional Information:
Study ID Numbers: 20010223;
Study Start Date:
Record last reviewed: January 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00043186
Other Osteoporosis Studies:
1. Low-Dose Hormone Replacement Therapy and Alendronate for Osteoporosis
2. Phase II Randomized Study of Alendronate Sodium for Osteopenia in Patients with Gaucher's Disease
3. Diagnostic Pilot Study of Dual Energy Absorptiometry in the Detection of Osteopenia or Osteoporosis in Patients With Thalassemia Major
4. Phase 2 Study assessing AMG 162 in the treatment of women with low bone density
5. Nitroglycerin Ointment for Preventing Bone Loss in Postmenopausal Women
Related Studies:
Other Osteoporosis Clinical Trials
Other Florida Clinical Trials
Other Palm Springs Clinical Trials
Phase 2 Study assessing AMG 162 in the treatment of women with low bone density
|
|
|
|
|
|
|
|
